News
February 5, 2019

Regenstrief Scientist Says African Americans Have Higher Rate of Alzheimer’s Disease, Quoted in USA Today

Daniel Bateman, M.D., says a number of studies show a higher rate of Alzheimer’s disease in African Americans. He told USA Today there are some hypotheses to explain this.

“There are higher rates of diabetes, hypertension, high cholesterol, heart disease and diabetes in African Americans compared to whites. All of those are risk factors for Alzheimer’s and dementia,” said Dr. Bateman. He points to a 2018 study, which also looked at a number of factors of people who have had a stroke, that found that African Americans had an increased rate for all five types of dementia.

Joanne Pike, vice president of programs for the Alzheimer’s Association in Chicago, says that African Americans are twice as likely to have Alzheimer’s, less likely to receive a diagnosis and more likely to be diagnosed in later stages of the disease. Researchers are looking at many avenues to understand the reasons why.

Regenstrief Institute does a large amount of work in the area of Alzheimer’s and dementia. From testing new care models to decision support and the effects of medication on the brain.  Dr. Bateman’s work is focused on Alzheimer’s disease, specifically innovative approaches to measure and treat behavioral and psychological symptoms of dementia by leveraging technologies. He serves as a co-investigator on the Indiana Alzheimer Disease Center (IADC) Outreach and Recruitment (OR) Core and contributes to the IADC Clinical Core.

Read the USA Today article featuring Dr. Bateman here.

  • Daniel Bateman

Related News

Arthur Owora, PhD

Machine learning tool improves pediatricians’ ability to identify children at risk for persistent asthma 

Pilot randomized trial finds EHR-integrated decision support improved clinicians’ prediction of school-age asthma  A machine learning tool that analyzes

Health First Indiana generated estimated $742.6 million in savings through key public health services

An analysis from the Regenstrief Institute found that Health First Indiana (HFI), the state’s landmark public health funding initiative,

Office of Strategic Innovation helps connect startups with research expertise

Moving healthcare innovations from promising ideas to real-world impact requires collaboration between researchers, entrepreneurs, healthcare organizations and industry partners.

e-star logo

First E-STAR annual report offers unprecedented view of early access to kidney transplantation

National registry data reveal opportunities to improve referral, evaluation and waitlisting for patients with kidney failure Chronic kidney disease